To Get Help Now
Click Here
 
Today's Date:

AstraZeneca To Face Trial Over Seroquel Sales

AddThis Social Bookmark Button

Arkansas Circuit Judge Chris Piazza has ruled that AstraZeneca will stand trial in September 2012, over a lawsuit filed by Arkansas Attorney General Dustin McDaniel, alleging that AstraZeneca knew about and hid the side effects and health risks of the Seroquel while selling it to patients on the Arkansas Medicaid program.

According to Bloomberg, AstraZeneca has agreed to pay nearly $1 billion to resolve claims of deceptive marketing in 37 states and has been charged by Arkansas officials with defrauding the Medicaid program by failing to properly outline health risks on the warning label. Arkansas is seeking $5,000 penalty for each Seroquel prescription written as far back as 1997. AstraZeneca has reported they have resolved nearly two-thirds of the 26,000 product liability lawsuits filed over Seroquel, that claim the company marketing the drug for off-label uses that were not approved by the FDA.

Lawyers for the state of Arkansas contend that AstraZeneca knew before the drug hit the market in 1997, that it could cause some users to gain weight and develop diabetes.

Judge Piazza threw out claims for damages of Seroquel sales under Arkansas consumer protection laws, but the Medicaid fraud claims stand.

 

 

breakinglawsuitnews.com disclaimer: This article: AstraZeneca To Face Trial Over Seroquel Sales was posted on Tuesday, July 19th, 2011 at 9:17 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.